Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone marrow transplantation in leukemia: possibilities and problems]

B Speck

    Schweizerische Medizinische Wochenschrift
    |October 4, 1975
    PubMed
    Summary

    Clinical bone marrow transplantation offers a cure for acute refractory leukemias. Success requires careful donor selection, optimal patient conditioning, and experienced medical teams for best outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cyclosporin A in human transplantation.

    Immunology today·2014
    Same author

    T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.

    Blood·2000
    Same author

    Treatment of solid tumors following allogeneic bone marrow transplantation.

    Bone marrow transplantation·2000
    Same author

    High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia--A possible role of high endogenous IL-2 in their suppression.

    Acta haematologica·1999
    Same author

    [25 years allogenic bone marrow transplantation in Basel: 1973-1998].

    Schweizerische medizinische Wochenschrift·1998
    Same author

    [Optimizing plasma cell content in bone marrow aspirates].

    Schweizerische medizinische Wochenschrift·1998

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Acute refractory leukemias present a significant therapeutic challenge.
    • Bone marrow transplantation (BMT) has advanced, offering potential cures for select patients.
    • Successful BMT hinges on meticulous pre-transplant protocols.

    Observation:

    • Histocompatibility typing between donor and host is crucial for graft acceptance.
    • Graft timing is critical; transplantation should avoid terminal disease stages.
    • Recipient conditioning must balance immunosuppression for engraftment with tumor burden reduction.

    Findings:

    • Optimal conditioning involves both immunosuppression and maximal tumor reduction.
    • A highly skilled team is essential for comprehensive supportive care.
    • Current best practice restricts marrow donors to Human Leukocyte Antigen (HLA)-identical, Mixed Leukocyte Culture (MLC)-negative siblings or identical twins.

    Implications:

    • BMT represents a viable curative option for specific leukemia patients.
    • Strict donor selection criteria (HLA-identical, MLC-negative) are paramount.
    • Further research may expand donor eligibility and improve conditioning regimens.

    Related Experiment Videos